Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
10,53 USD | -2,32% | -11,29% | +32,29% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 1,06 mld. 993 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -195 mln. -183 mln. | Nettowinst (verlies) 2025 * | -209 mln. -197 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 92,93 mln. 87,39 mln. | Nettoliquiditeiten 2025 * | 93,52 mln. 87,94 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-5,79
x | K/w-verhouding 2025 * |
-6,08
x | Werknemers | 76 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 88,4% |
Recentste transcriptie over Centessa Pharmaceuticals plc
1 dag | -2,32% | ||
1 week | -11,29% | ||
Lopende maand | -6,81% | ||
1 maand | -0,85% | ||
3 maanden | +38,01% | ||
6 maanden | +50,21% | ||
Lopend jaar | +32,29% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Saurabh Saha
CEO | Chief Executive Officer | 47 | 01-01-21 |
Director of Finance/CFO | 53 | 01-02-21 | |
Ellie Im
CTO | Chief Tech/Sci/R&D Officer | - | 03-10-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 61 | 23-02-21 | |
Chairman | 54 | 01-11-20 | |
Brett Zbar
BRD | Director/Board Member | 51 | 01-01-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.02% | 0 M€ | 0,00% | - | |
0.01% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 10,53 | -2,32% | 109 521 |
17-04-24 | 10,78 | -2,27% | 120 741 |
16-04-24 | 11,03 | +2,32% | 197 243 |
15-04-24 | 10,78 | -4,77% | 72 576 |
12-04-24 | 11,32 | -4,63% | 186 748 |
uitgestelde koers Nasdaq, 18 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+32,29% | 1,06 mld. | |
-1,82% | 41,35 mld. | |
+44,25% | 40,38 mld. | |
+2,56% | 39,05 mld. | |
-12,11% | 26,67 mld. | |
+3,09% | 24,07 mld. | |
-24,16% | 18,36 mld. | |
+22,12% | 11,6 mld. | |
-3,74% | 11,68 mld. | |
+7,75% | 11,15 mld. |